Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $25.82, with a market capitalization of 146.96B. The stock trades at a price-to-earnings (P/E) ratio of 19.67 and offers a dividend yield of 6.7%.
On 2026-05-21, Pfizer(PFE) stock traded between a low of $25.79 and a high of $25.82. Shares are currently priced at $25.82, which is +0.1% above the low and 0.0% below the high.
The Pfizer(PFE)'s current trading volume is 54.49K, compared to an average daily volume of 36.9M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.81.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.81.
PFE News
BMO Capital analyst Evan Seigerman maintained a Buy rating on Pfizer yesterday and set a price target of $34.00. Meet Samuel – Your Personal Investing Prophet S...
Earlier in May 2026, Pfizer reported strong Phase 2 data for its investigational 25‑valent pneumococcal conjugate vaccine in infants and secured a European Comm...
The study showed strong immune responses in infants compared with PREVNAR 20, supporting advancement into Phase 3 testing. Stronger Immune Response Against Ser...
Analyst ratings
54%
of 28 ratingsMore PFE News
Tuesday’s total option volume of 63.3 million contracts resulted in net open interest growth of 7.39 million calls and 6.34 million puts. Tesla (TSLA), NVIDIA (...
Pfizer (PFE) announced data from its Phase 2 study evaluating the safety, tolerability and immunogenicity of a four-dose series of its investigational 25-valent...
Pfizer (NYSE:PFE) and Arvinas entered a global license agreement with Rigel Pharmaceuticals to commercialize VEPPANU for advanced or metastatic ER+/HER2- breast...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment By Alex Sirois Published May 19, 10:46AM EDT Quick Read Pfizer (PFE) tr...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock hedge fund-level data...
Advertisement Pfizer stock snapshot and recent performance Pfizer (PFE) is back in focus for investors, with the stock closing at US$25.33 and showing mixed p...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.